Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
05/2012
05/30/2012CN102482337A 吡咯啉-5-羧酸还原酶1的突变蛋白 Pyrroline-5-carboxylate reductase 1 mutant proteins
05/30/2012CN102482281A 吡咯并[2，3-d]嘧啶衍生物 Pyrrolo [2,3-d] pyrimidine derivatives
05/30/2012CN102482276A 杂环化合物及其用途 Heterocyclic compounds and their use
05/30/2012CN102482263A 苄基哌啶化合物 Benzylpiperidine compound
05/30/2012CN102482256A N-取代的环状氨基衍生物 N- substituted cyclic amino derivative
05/30/2012CN102482228A 含有内酰胺或苯磺酰胺化合物的药物 Drug-containing lactam or benzenesulfonamide compound
05/30/2012CN102482220A 含氮环酰基胍衍生物 Acyl derivatives of nitrogen-containing cyclic guanidine
05/30/2012CN102481295A 利用锰配合物化合物与所述化合物之非锰配合物形式的组合的药物组合物和治疗方法 Pharmaceutical compositions and methods of treatment using the compounds of the manganese complexes in the form of a non-manganese complexes with the compound of the combination
05/30/2012CN102481274A 治疗或预防疲劳的方法 A method of treating or preventing fatigue
05/30/2012CN102475843A 一种治疗盗汗的中药制剂 A Chinese medicine preparation for treating night sweats
05/30/2012CN102475826A 女性丰乳美体片 Female Breast and Body sheet
05/30/2012CN102475819A 植物溶血片 Plants hemolysis sheet
05/30/2012CN102475815A 一种具有活血化瘀作用的胶囊剂及其制备方法 Capsule and its preparation method has the effect of promoting blood circulation
05/30/2012CN102475799A 一种能治疗自汗的中药制剂 One kind of Chinese medicine to treat spontaneous
05/30/2012CN102475718A 禽用转移因子可溶性粉剂及其制作工艺和质量检验方法 Avian transfer factor soluble powder with its production process and quality inspection methods
05/30/2012CN102475175A 一种缓解风热感冒茶 One kind of tea to ease Fengreganmao
05/30/2012CN102114182B Compound preparation for resisting heat stress and heat fatigue
05/30/2012CN102078367B Use of aidi preparation in preparation of medicaments for treating multiple organ dysfunction syndrome in elderly
05/30/2012CN101904831B Application of alkannin and compositions thereof
05/30/2012CN101805336B Compound containing tryptophane and isoxazole skeleton and preparation method and application thereof
05/30/2012CN101766258B Pig feed additive and application thereof
05/30/2012CN101732287B Injection of mannite and glycerol and preparation method thereof
05/30/2012CN101573361B Novel aminopyrimidine derivative as plk1 inhibitor
05/30/2012CN101479254B C-phenyl 1-thioglucitol compound
05/30/2012CN101402630B Preparation of losartan
05/30/2012CN101400657B Polycyclic cinnamide derivative
05/30/2012CN101267819B Combination of a long-acting hypnotic agent and a short-acting hypnotic agent
05/29/2012US8188276 2,4-pyrimidinediamine compounds and their uses
05/29/2012US8188275 hydrolase enzyme inhibors such as 2-(6-Chloro-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-ylmethyl)-benzonitrile
05/29/2012US8188228 Nucleic acid and corresponding protein entitled 193P1E1B useful in treatment and detection of cancer
05/29/2012US8188146 Highly purified ethyl EPA and other EPA derivatives
05/29/2012US8188074 Biologically active methylene blue derivatives
05/29/2012US8187588 Mycoplasma hyopneumoniae bacterin vaccine
05/29/2012CA2555624C Thioamide compounds or salts thereof and cytokine production inhibitors containing the same
05/29/2012CA2496127C Piperidinyl compounds that selectively bind integrins
05/29/2012CA2481036C (3z)-(3-(3-hydro-isobenzofuran-1-ylidene)-1,3-dihydro-2h-indol-2-ones as kinase inhibitors
05/29/2012CA2442168C N-acetylcysteine compositions and methods for the treatment and prevention of drug toxicity
05/29/2012CA2441597C Elongated and multiple spacers in activatible prodrugs
05/29/2012CA2426393C Crystalline forms of venlafaxine hydrochloride
05/29/2012CA2403817C Methods of modulating hair growth
05/29/2012CA2395053C Novel serpentine transmembrane antigens expressed in human cancers and uses thereof
05/29/2012CA2389429C Compositions and methods for counteracting effects of reactive oxygen species and free radicals
05/29/2012CA2368855C Differentiation of monocytes into functional dendritic cells
05/29/2012CA2338005C Peptide antagonists of zonulin and methods for use of the same
05/29/2012CA2321596C Use of skin penetration enhancers and barrier disruption agents to enhance the transcutaneous immune response induced by adp-ribosylating exotoxin
05/29/2012CA2318731C Ppar-gamma modulators
05/29/2012CA2280736C Methods for modulating hematopoiesis and vascular growth
05/29/2012CA2220777C Novel heterocycles as inhibitors of leucocyte adhesion and as vla-4 antagonists
05/24/2012WO2012067224A1 Therapeutic or prophylactic agent for corneal epithelium disorders and/or conjunctival epithelium disorders
05/24/2012WO2012066994A1 Pharmaceutical formulation having neuroprotective activity
05/24/2012WO2012066581A1 Novel conjugates for targeted drug delivery
05/24/2012WO2012066546A1 Aminoglycosides and uses thereof in treating genetic disorders
05/24/2012WO2012065751A1 Bio-functionalized stimulus-responsive dissolvable peg-hydrogels
05/24/2012US20120129932 Composition based on substituted 1,3-diphenylprop-2-en-1-one derivatives, preparation and uses thereof
05/24/2012US20120129930 Ketone compounds and compositions for cholesterol management and related uses
05/24/2012US20120129919 Polycationic amphiphilic cyclooligosaccharides and the use thereof as molecular transporters
05/24/2012US20120129827 Novel derivatives of 1-alkyl-6-oxo-piperidine-3-carboxylic acids and 1-alkyl-5-oxo-pyrrolidine-3-carboxylic acids and their uses as cooling compounds
05/24/2012US20120129178 Genomic polymorphism for predicting therapeutic response
05/24/2012US20120128774 Maxillofacial bone augmentation using rhpdgf-bb and a biocompatible matrix
05/24/2012US20120128679 Human Antibodies to the Glucagon Receptor
05/24/2012DE19780092B3 Verwendung eines Extrakts von Eriobotrya japonica insbesondere auf dem Gebiet der Kosmetik zur Stimulierung der Synthese der Glycosaminoglycane Use of an extract of Eriobotrya japonica and in particular the cosmetic field for stimulating the synthesis of glycosaminoglycans
05/24/2012CA2818583A1 Novel conjugates for targeted drug delivery
05/24/2012CA2817505A1 Pharmaceutical formulation having neuroprotective activity
05/24/2012CA2816789A1 Aminoglycosides and uses thereof in treating genetic disorders
05/23/2012EP2455467A1 Double-stranded oligonucleotides
05/23/2012EP2455466A1 Dna fragment and pharmaceutical composition
05/23/2012EP2455396A1 Sugar chain-added ailim extracellular domain and method for producing same
05/23/2012EP2455381A1 Triazolopyridine compound, and action thereof as prolyl hydroxylase inhibitor and erythropoietin production inducer
05/23/2012EP2455380A1 Heterocyclic compound and use thereof
05/23/2012EP2455379A1 Crystals of pyrroloquinolinequinone sodium salts
05/23/2012EP2455370A1 Pharmaceutical product containing lactam or benzene sulfonamide compound
05/23/2012EP2455104A1 Bio-functionalized stimulus-responsive dissolvable PEG-hydrogels
05/23/2012EP2455096A1 Oxidized protein hydrolase activity enhancer
05/23/2012EP2455089A1 Inhibitor of blood gip level elevation
05/23/2012EP2455082A1 Insulin-producing cell inducer, glucose intake enhancer, and therapeutic agent for diabetes or diabetes complications
05/23/2012EP2455071A1 Capsule Formulation
05/23/2012EP2455070A1 Capsule Formulation
05/23/2012EP2454240A1 Glycine transporter inhibitors
05/23/2012EP2453909A2 Antigen compositions and methods of inhibiting campylobacter jejuni bacterial infection and uses of the antigen compositions
05/23/2012EP2453899A1 Humic substances and therapeutic uses thereof
05/23/2012EP2191836B1 Prophylactic or alleviating agent for peripheral nerve disorder induced by anti-cancer agent
05/23/2012EP2036903B1 Potentiator of radiation therapy
05/23/2012EP1932522B1 Therapeutic agent for liver disease containing 2-amino-1,3-propanediol derivative as active ingredient
05/23/2012EP1548435B1 Diagnostic method for eating disorders
05/23/2012EP1509610B1 Transgenic plants with controlled distribution of a trait to progeny
05/23/2012EP1474408B1 N-phenyl-2-pyrimidine-amine derivatives
05/23/2012EP1446418B1 Integrin targeting compounds
05/23/2012EP1325014B1 Gamma-hydroxybutyrate compositions containing carbohydrate carriers
05/23/2012CN1964733B Novel use of peptide compounds for treating essential tremor
05/23/2012CN1906162B Hydroxy piperidine derivatives to treat gaucher disease
05/23/2012CN1659288B Pharmaceutical composition for preventing or reducing DNA damage
05/23/2012CN1561340B Novel 1,2,4-triazole compound
05/23/2012CN102471369A 肽类化合物及其用途 Peptide compounds and their uses
05/23/2012CN102471355A 二苯硫醚衍生物和含有其作为活性成分的药物 Diphenyl sulfide derivative and a pharmaceutical containing it as an active ingredient
05/23/2012CN102471337A Triazolopyridine compound, and action thereof as prolyl hydroxylase inhibitor or erythropoietin production-inducing agent
05/23/2012CN102471336A 吡咯并喹啉醌的钠盐结晶 Pyrrolo-quinoline quinone and the crystalline sodium salt of
05/23/2012CN102471335A Azabicyclo compound and salt thereof
05/23/2012CN102471333A 新型噻吩甲酰胺衍生物及其药物用途 Novel thiophene carboxamide derivatives and pharmaceutical use
05/23/2012CN102471276A 新型四氢异喹啉化合物 Novel tetrahydroisoquinoline compounds
05/23/2012CN102470169A Autoantibody production inhibitor
1 ... 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 ... 1564